Needham & Company Upgrades CryoLife (CRY) to Buy
Tweet
Share
E-mailGet Alerts CRY Hot Sheet
Price: $17.44 -1.36%
Rating Summary:
6 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
6 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Needham & Company analyst Matt Matson upgraded CryoLife (NYSE: CRY) from Hold to Buy.
For an analyst ratings summary and ratings history on CryoLife click here. For more ratings news on CryoLife click here.
Shares of CryoLife closed at $24.64 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- XTI Aerospace CEO resigns amid internal review and late SEC filing
- Analog Devices (ADI) PT Raised to $450 at Needham
Create E-mail Alert Related Categories
UpgradesRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
